Barclays PLC Prestige Consumer Healthcare Inc. Transaction History
Barclays PLC
- $436 Billion
- Q2 2025
A detailed history of Barclays PLC transactions in Prestige Consumer Healthcare Inc. stock. As of the latest transaction made, Barclays PLC holds 124,231 shares of PBH stock, worth $8.11 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
124,231
Previous 124,231
-0.0%
Holding current value
$8.11 Million
Previous $9.92 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding PBH
# of Institutions
398Shares Held
52.5MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY8.28MShares$540 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$368 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.47MShares$161 Million0.05% of portfolio
-
Ariel Investments, LLC Chicago, IL2.2MShares$144 Million2.24% of portfolio
-
State Street Corp Boston, MA2MShares$131 Million0.01% of portfolio
About Prestige Consumer Healthcare Inc.
- Ticker PBH
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,762,600
- Market Cap $3.25B
- Description
- Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's an...